Readings Week 2 PDF

Patient education and Health promotion page:1085 - Prevention is a valuable strategy to reduce the incidence, morbidly, and mortality of meningitis. - HIB and pneumococcal vaccines have proved to be effective in lowering the attack rate in all ages, they should be strongly encourag...

Patient education and Health promotion page:1085 - Prevention is a valuable strategy to reduce the incidence, morbidly, and mortality of meningitis. - HIB and pneumococcal vaccines have proved to be effective in lowering the attack rate in all ages, they should be strongly encouraged for infants. - PCV 23 should be given to immunocompromised, aslpenic, and chronic diseases such as HF, lung diseases, diabetes, tobacco use, liver disease and alcoholism. - PCV 13 and PPSV 23 are now recommended for adults over 65. - MCV 4 is routinely given to children aged 11-12. A booster is given at 16 because the protection wanes after 5 years, and rates of meningitis peak at ages 16-21. - MCV 4 should be given to adults living in college dorms, military recruits, complement deficiency or asplenia, spending time in endemic arras, and scientists working with the casual organism. - Chemoprophylaxis for close contacts of patients with N. meningitides or H. influenzae infections include rifampin 600 mg BID for 2 days, ceftriaxone 250 mg IM single dose, or ciprofloxacin 500 mg single dose. Chapter 222 vaccine for meningitis page 1393 - FDA approved HPV vaccine for girls 9-26 and males 9-21. Protects against HPV that can cause cervical, vaginal, vulvar, and anal cancers. - Hep B vaccine is available for all age groups to prevent HBV infection. Chapter 51: Indication for tetanus immunization - Tetanus immunizations should be reviewed for all patients with after any type of tissue trauma. - If immunization state is unknown, not given a booster in 10 years, or if the patient received \< 3 lifetime doses, Td toxoid and TIG should be given. - All age groups are currently recommended to receive one dose of Tdap immunization. - Once Tdap is given to an adult, one dose of Td is recommended to patients with tetanus prone (and contaminated) wounds if the previous immunization was \> 5 years ago. - Tetanus prone wounds: Td and TIG if \< 3 lifetime doses. If \> 3 lifetime doses, then just Td if \> 5 years since booster. - Non tetanus prone wounds: Td if \< 3 lifetime doses. If \> 3 lifetime doses, then just Td if \> 10 years since booster.